中裕

-1.80 (-2.92%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

59.80826成交張數–本益比4.40股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度	營收(億)	營收年增	毛利(億)	毛利率	營業利益(億)	營業利益率	淨利率
2026Q2	1.6	13.3%	0.8	50.7%	-0.7	-47.9%	-46.7%
2026Q1	1.7	-5.8%	1.0	62.5%	0.0	1.4%	9.8%
2025Q4	1.5	2.8%	0.4	28.9%	-0.9	-58.3%	-45.7%
2025Q3	1.5	6.6%	0.6	38.9%	-0.3	-18.7%	-9.5%
2025Q2	1.4	-6.4%	0.7	49.0%	-0.5	-33.6%	-43.2%
2025Q1	1.8	-1.5%	0.9	51.8%	-0.3	-18.9%	-14.6%
2024Q4	1.5	-7.9%	0.1	6.7%	-1.3	-88.2%	-82.7%
2024Q3	1.4	-12.1%	0.8	54.4%	-0.5	-32.8%	-27.3%
2024Q2	1.5	41.0%	0.6	39.4%	-0.4	-28.1%	-18.7%
2024Q1	1.8	149.3%	0.7	38.1%	-0.4	-20.7%	-9.0%
2023Q4	1.6	-51.5%	0.7	43.7%	-0.3	-16.8%	-38.1%
2023Q3	1.6	63.1%	0.8	49.1%	-0.0	-2.1%	-3.7%
2023Q2	1.0	5.0%	0.3	32.5%	-0.7	-62.6%	-45.9%
2023Q1	0.7	76.5%	0.4	62.6%	-0.7	-99.1%	-112.6%
2022Q4	3.3	330.4%	1.3	40.0%	0.3	7.8%	-11.6%
2022Q3	1.0	6.0%	0.3	35.1%	-0.6	-61.5%	-37.3%
2022Q2	1.0	-36.0%	0.5	50.8%	-0.6	-56.0%	-76.3%
2022Q1	0.4	-55.4%	0.0	1.5%	-1.0	-251.3%	-294.5%
2021Q4	0.8	-50.2%	-0.5	-67.1%	-2.4	-319.3%	-393.8%
2021Q3	0.9	-40.0%	0.4	46.8%	-0.7	-75.1%	-85.5%
2021Q2	1.6	-13.3%	0.6	39.9%	-0.9	-57.9%	-64.0%
2021Q1	0.9	-61.9%	0.3	33.1%	-0.9	-94.1%	5.4%
2020Q4	1.5	-27.1%	0.6	41.3%	-1.2	-76.6%	-60.3%
2020Q3	1.5	-28.3%	0.6	36.3%	-0.6	-37.8%	-30.6%
2020Q2	1.8	15.3%	0.7	41.6%	-0.0	-1.2%	17.0%
2020Q1	2.4	86.4%	1.3	53.9%	0.4	18.2%	-31.5%
2019Q4	2.1	81.7%	0.8	38.8%	-0.0	-0.3%	-39.1%
2019Q3	2.1	141.9%	1.0	47.5%	-2.5	-117.5%	-152.4%
2019Q2	1.6	304.4%	0.3	17.3%	-0.7	-48.0%	-53.8%
2019Q1	1.3	–	0.2	16.8%	-0.7	-51.3%	-70.5%
2018Q4	1.2	4679.8%	0.2	19.5%	-1.2	-104.8%	-133.2%
2018Q3	0.9	3541.9%	-0.3	-32.0%	-1.5	-172.6%	-407.2%
2018Q2	0.4	1496.0%	-0.1	-19.0%	-1.4	-355.9%	158.8%
2018Q1	0.0	-100.0%	-0.1	–	0.9	–	–
2017Q4	0.0	286.2%	0.0	100.0%	-1.8	-7340.1%	-6925.5%
2017Q3	0.0	286.2%	0.0	100.0%	-1.1	-4391.7%	-4346.0%
2017Q2	0.0	287.0%	0.0	100.0%	-1.9	-8003.7%	-7152.0%
2017Q1	0.0	485.1%	0.0	100.0%	-0.7	-5776.5%	-6673.2%
2016Q4	0.0	–	0.0	100.0%	-1.2	-18463.2%	-17329.4%
2016Q3	0.0	–	0.0	100.0%	-0.6	-8975.1%	-7816.5%